Credits: Canva
Everyone likes when their hard work pays off. Years of service is usually awarded by foreign trips or retiring abroad. This is the life when you transition to a life of non-work activities, whether it is travelling, diving into personal projects or even learning or new language. However, while all these plans to do all this in an affordable country seem like a great warm experience, it may have its downside: loneliness.
A latest study published in Psychology and Aging, titled Trouble In Paradise? Emotional and Social Loneliness Among International Retirement Migrants, suggests that retirees who move abroad often experience a greater social isolation than those who say in their home state.
The researchers compared nearly 5,000 Dutch retirees living abroad to more than 1,300 who stayed in Netherlands. The study found that retirees who moved overseas were socially isolated and even though they were also often healthier and wealthier than the ones who stayed back.
The lead author of the study, Esma Betül Savaş, who is also a doctoral researcher at the Netherlands Interdisciplinary Demographics Institute said in a news release, "although these retirement migrants generally report being happy, they may still face struggles adapting to a new country."
This happens when you have a lack of broad circle of friends, whereas emotional loneliness is tied to lack of close friends and partners. You may have tons of friends, but no one to share deep thoughts with.
However, those who stayed back stayed connected with their friends and family back home, in fact, some of them were able to strengthen their relationships after retirement. However, there was also another group of retirees, those who built strong relationships in their new country and felt less isolated.
Researchers also found that those who engaged with their neighbors and felt a sense of belonging in their new home had lower levels of social loneliness. “Older adults may face double jeopardy in retiring to a new country as they are vulnerable to both age-related and migration-related risk factors for loneliness, and loneliness is itself a risk factor for adverse health outcomes,” Savaş said.
“It’s important for people considering retirement migration to think about how they can maintain their social ties in their origin country and make new ones in their destination country,” she concluded.
ALSO READ: How Old Are Your Organs? New Study Links Organ Aging to Disease Risk
As per the National Institute on Aging, social isolation and loneliness may be bad for brain health. These have been linked to poorer cognitive function and higher risk of dementia, including Alzheimer's disease. Furthermore, little social activity and being alone also makes it more difficult to perform everyday tasks such as driving, paying bills, taking medicines, and cooking.
Credits: Instagram
Netflix and adult film star Kylie Page's sudden death just at the age of 28 has come has a shock for the entertainment industry and her family. She was found dead at her apartment on June 25 after a friend called the cops when the friend was unable to reach her.
By the time the fire department arrived at her Hollywood residence, she had already been pronounced dead.
"The Brazzers team is deeply saddened to learn of Kylie Page’s passing,” the company said in a statement on X. “Kylie will be remembered for her laughter, kindness, and bringing light wherever she went. We extend our heartfelt condolences to Kylie’s family, friends, and fans during this difficult time.”
In case of Page, fentanyl and drug paraphernalia was found in her home.
As per the Edge Treatment Center that is licensed by the California State Department of Health Care Services, and US federal law, drug paraphernalia is any device, item, or component of any type which is mainly meant or crafted for the purpose of production, compounding, transforming, obscuring, generating, processing, prepping, injecting, inhaling, consuming, or otherwise including a banned drug into our bodies.
As per the United States Drug Enforcement Administration (DEA), fentanyl is a potent synthetic opioid drug approved by the Food and Drug Administration for use as an analgesic (pain relief) and anesthetic. It is approximately 100 times more potent than morphine and 50 times more potent than heroin as an analgesic.
It is also known as Apace, China Girl, China Town, Dance Fever, and by other various names. It can be consumed through snorting, sniffing, smoking, or orally by pill or tablet. It could also be spiked onto blotter paper, patches or sold alone or in combination with heroin and other substances.
As per the National Institute on Drug Abuse, US, Fentanyl and other illegally produced synthetic opioids have played a major role in the overdose crisis in the United States since 2013.
Since about 2017, overdose deaths often involve use of multiple drugs. In many cases, fentanyl is one of these drugs. When fentanyl is mixed with other drugs, either on purpose or unknowingly, the combination can have more serious health effects.
Like other opioid pain relievers, fentanyl can cause a range of effects including relaxation, euphoria, pain relief, sedation, confusion, drowsiness, dizziness, nausea, vomiting, urinary retention, constricted pupils, and slowed breathing.
In cases of overdose, symptoms may include stupor, altered pupil size, cold and clammy skin, bluish discoloration (cyanosis), coma, and respiratory failure, which can be fatal. A combination of coma, pinpoint pupils, and respiratory depression is a strong indicator of opioid intoxication.
Credits: Canva
The U.S. Food and Drug Administration (FDA) has announced a significant update to the labeling of all extended-release medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD). The change specifically targets the use of these drugs in children younger than six, warning about the risk of weight loss and other adverse reactions.
ADHD is a common neurodevelopmental disorder that typically begins in childhood. It is characterized by symptoms such as inattention, hyperactivity, and impulsivity that can interfere with a child's development and daily functioning. Treatment usually involves a combination of behavioral therapy and medication, including stimulants like amphetamines and methylphenidate.
Although extended-release stimulants are not approved for use in children under six, the FDA notes that healthcare professionals sometimes prescribe them “off-label” to younger patients. This is typically done in cases where other treatments have failed or when symptoms are especially severe. However, the FDA warns that clinical trials have shown young children process these drugs differently from older children, often resulting in higher concentrations of the medication in the body.
These higher drug levels have been associated with an increased likelihood of side effects, including clinically significant weight loss. As a result, the FDA is requiring drug manufacturers to include a new “Limitation of Use” section in the prescribing information for all extended-release stimulant medications.
This section will outline the risks specific to children under six, including:
For young children already taking extended-release ADHD stimulants, the FDA advises healthcare providers to closely monitor the patient’s growth and development. Pediatricians should regularly chart weight and height to detect early signs of weight loss. If weight loss becomes a concern, alternative treatments should be considered.
These may include:
Parents and caregivers are encouraged to stay alert for signs of weight loss in children taking extended-release stimulants. If any concerning changes in appetite or weight are noticed, it’s essential to consult the child’s pediatrician. The doctor can then weigh the benefits and potential harms of continuing the current medication and discuss safer alternatives if needed.
The FDA's move comes as part of its ongoing effort to improve pediatric medication safety and ensure that drug use in children is backed by evidence, especially when used outside of official guidelines.
Credits: Wikimedia Commons
Kate Middleton or Catherine, Princess of Wales reflected on the aftermath of chemotherapy in her first public appearance since she had unexpectedly withdrawn from Royal Ascot just two weeks ago.
She has called the entire experience "really difficult". On her visit to a wellbeing garden at Colchester Hospital in Essex, England on Wednesday, she told the patients, "You put on a sort of brave face, stoicism through treatment, treatment’s done – then it’s like ‘I can crack on, get back to normal.’ But actually the phase afterwards is really difficult, you’re not necessarily under the clinical team any longer, but you’re not able to function normally at home as you perhaps once used to."
The reason she visited the hospital garden in the Southeast of England was to "celebrate the incredible healing power of nature", noted Kensington Palace.
She also met with patients and hospital staff at the Cancer Wellbeing Centre "to understand how gardens in healthcare setting play a crucial role in promoting good health outcomes, preventing poor health and supporting increased recovery time."
Now 43, Kate herself has pointed out to the importance of nature in her health journey over the last year.
Lisa A Cooper, MD, MPH writes in the 'Letter from the Director' at John Hopkins Medicine that nature does have healing power. She notes that green spaces play a role in cardiovascular health, and also facilitates to interact with other people who are there to enjoy nature. The American Psychological Association (APA) also noted that spending time in nature is linked to both cognitive benefits and improvements in mood, mental health and emotional well-being. The University of Cincinnati also points out that being out in nature can further reduce anxiety, lower blood pressure, enhance immune system function, and boost self esteem and mood.
In fact in a video, which was posted by Kate on X to mark Mental Health Awareness Week in May, she said, "over the past year, nature has been my sanctuary."
In March, Princess Kate publicly shared her cancer diagnosis and confirmed she had begun chemotherapy. As she focused on her recovery, she stepped away from the public eye, making only a few limited appearances over the summer. By September, she announced she had completed chemotherapy and was "doing what I can to stay cancer-free."
Since then, the Princess of Wales has been gradually re-engaging with her royal responsibilities. While she has increased her public appearances this year, palace insiders say she is carefully managing her return to balance her health with her official duties.
Earlier this summer, Kate made high-profile appearances at key royal events, including the Trooping the Colour parade in London and the Order of the Garter service in Windsor. However, she later withdrew from the Royal Ascot at the last minute, signaling that her return to full-time royal duties is still being handled with care.
Just last week, Kate resumed in-person engagements, joining Prince William in hosting philanthropist Melinda French Gates at Windsor Castle. The meeting, reportedly focused on their shared philanthropic interests, marked one of her first official engagements in recent weeks.
On Wednesday, the Princess made a meaningful visit to Colchester Hospital, where she helped plant several “Catherine’s Rose” plants—a specially bred rose named in her honor by the Royal Horticultural Society. The visit coincided with the hospital receiving a donation of 50 such plants.
The rose holds special significance: proceeds from its commercial sale will go to The Royal Marsden Cancer Charity, supporting cancer patients through treatment and beyond. The funds will help the charity develop a dedicated program focused on improving quality of life for those living with cancer and those who have completed treatment.
Also Read: Why Everyone Is Suddenly Talking About Ivermectin As A Cancer Breakthrough?
Princess Kate has deepened her connection with the Royal Marsden since her diagnosis. In January, Kensington Palace announced she had been named joint patron of The Royal Marsden NHS Foundation Trust, the specialist cancer center in Chelsea, west London, where she received treatment.
Her involvement with the charity and efforts to raise awareness reflect her commitment to supporting others navigating a cancer diagnosis. While her return to public life is cautious and measured, each appearance signals both her resilience and her intention to use her platform for meaningful causes.
As she continues to recover and adjust, the Princess of Wales remains one of the most admired and closely followed members of the royal family—balancing personal healing with her public role.
© 2024 Bennett, Coleman & Company Limited